EP2791103
Afleiður af betúlíni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.12.2012EP published:
2.8.2017EP application number:
12857774.9
EP translation filed:
28.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
13.12.2032Expiry date:
13.12.2020
Title:
DERIVATIVES OF BETULIN
Timeline
Today
14.12.2012EP application
2.8.2017EP Publication
28.8.2017Translation submitted
15.9.2017Registration published
13.12.2020Expires
Owner
Name:
GlaxoSmithKline LLCAddress:
251 Little Falls Drive, 19808, Wilmington, DE, US
Inventor
Name:
HATCHER, Mark AndrewAddress:
Research Triangle Park, North Carolina, US
Name:
JOHNS, Brian, AlvinAddress:
Research Triangle Park, North Carolina, US
Name:
MARTIN, Michael, TolarAddress:
Research Triangle Park, North Carolina, US
Name:
TABET, Elie, AmineAddress:
Research Triangle Park, North Carolina, US
Name:
TANG, JunAddress:
Research Triangle Park, North Carolina, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161576448 PDate:
16.12.2011Country:
US
Classification
Categories:
C07C 69/753, C07J 63/00, A61K 31/56, A61P 31/18
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 13.11.2017
Expires: 13.12.2018
Payer: Örn Þór, slf.
Number: 7
Paid: 13.11.2018
Expires: 13.12.2019
Payer: Örn Þór, slf.
Number: 8
Paid: 14.11.2019
Expires: 13.12.2020
Payer: Örn Þór, slf.